Home > Investments > Private Equity Managers > CM Capital

CM Capital

www.cmcapital.com

CM Capital is a specialist venture capital manager based in Brisbane. The team invests in early stage companies in the life sciences, information technology and telecommunication sectors. Investments are generally funded over a number of years rather than with a single up-front amount. CM Capital’s previous investments include Pharmaxis, CathRx, Universal Biosensors (all listed on the Australian stock exchange) and Dilithium Networks.

 

CM Capital Venture Trust No.4

% of IPE assets

Altiris Inc

Drug company developing small molecule drug therapies

0.1

Sunshine Heart Inc

Developing a mechanical heart assist device

0.3

Mesaplexx

Superconductor frequency filters for wireless telecommunications

0.2

Osprey Medical Inc

Developing cardiovascular catheter systems

0.5

Piedmont Pharmaceuticals LLC

Specialty human and veterinary pharmaceuticals

0.9

AdGent 007, Inc

Online advertising filtering software

0.6

Ingenero

Green energy supplier

0.5

ThreatMETRIX Inc

Anti-fraud software for internet transactions

0.4

Pathway Therapeutics

Developing small molecule inhibitors for human cancers

0.2

Datacastle Corporation

Data protection software

0.4

SpeeDx Pty Ltd

Molecular diagnostics platform developer

0.0

Xumii

Delivery of applications and content to mobile devices

Sold F09

 

NOTE
Portfolio composition is based on valuations as at 31 March 2010. Valuations are conducted quarterly, as at the end of March, June, September and December.

Quick Contacts

General Enquiries
Email: ingpeal@ingim.com.au

Share Registry
Free Call: 1800 891 098 (Australian investors)
Free Call: 0800 507 120    (New Zealand investors)
Int'l: +61 2 8280 7185